Showing 611-620 of 3189 results for "".
Do More, Charge More: Keep Prices High and Still Crush the Competition
https://practicaldermatology.com/topics/practice-management/do-more-charge-more-keep-prices-high-and-still-crush-the-competition/23142/Enhance the patient experience to justify higher charges.Is “Offshore” Asset Protection Right for You?
https://practicaldermatology.com/topics/practice-management/is-offshore-asset-protection-right-for-you/20649/What to do—and not to do—in international planning.“Do you know how much this white cream costs?”
https://practicaldermatology.com/topics/practice-management/do-you-know-how-much-this-white-cream-costs/21077/Quality of Care in Atopic Dermatitis: We Can Do Better
https://practicaldermatology.com/topics/atopic-dermatitis/quality-of-care-in-atopic-dermatitis-we-can-do-better/23413/A global report identifies best practices to improve the patient experience and close gaps in care.Biologic Therapies for 2013: Do We Use Them Enough?
https://practicaldermatology.com/topics/psoriasis/biologic-therapies-for-2013-do-we-use-them-enough/22931/The Financial Contract Every Practice Must Have... And Very Few Do
https://practicaldermatology.com/topics/practice-management/the-financial-every-practice-must-have-and-very-few-do/21166/Three Reasons Why Your Practice Should Do Paid Search
https://practicaldermatology.com/topics/practice-management/three-reasons-why-your-practice-should-do-paid-search/23331/A look at the benefits for your practice.How Do You Compare? Financial Benchmarking Survey Measures Aesthetic Market
https://practicaldermatology.com/topics/practice-management/how-do-you-compare-financial-benchmarking-survey-measures-aesthetic-market/23002/Results of an annual benchmarking survey among medical aesthetic, dermatology, and medispa practices across the US.Second Primary Tumors and Immune Checkpoint Inhibitors: What Do We Know?
https://practicaldermatology.com/topics/skin-cancer-photoprotection/second-primary-tumors-and-immune-checkpoint-inhibitors-what-do-we-know/23452/New evidence reveals a potential link between ICI treatment and risk for secondary cancers.How do barrier dysfunction proteins interact with immune dysregulation to sustain AD?
https://practicaldermatology.com/videos/dermatology-hub-neuroimmune-network/how-do-barrier-dysfunction-proteins-interact-with-immune-dysregulation-to-sustain-ad/56736/Raj Chovatiya, MD, PhD, MSCI, FAAD, discusses whether barrier dysfunction drives inflammation and immune dysregulation, or vice versa, or both, in atopic dermatitis.